FAAH Inhibitor Trial for Adults With Tourette Syndrome
Status:
Terminated
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to examine the safety, tolerability and feasibility in the use
of a FAAH inhibitor for the treatment of adults with Tourette syndrome.